Dr. Jessica Jones
Medical Oncologist
1 Podcast on BackTable
Dr. Jessica Trevino Jones is a board certified internist and oncologist at the University of Texas Health Science Center in San Antonia, Texas.
Learn from the experiences and expertise of Dr. Jessica Jones and other leading voices in your specialty on the BackTable app.
Episode # 54 • 16 Jul 2024
Managing Sarcomas: A Multidisciplinary Approach
In this episode of The Back Table MSK Podcast, Dr. Alexa Levey discusses the importance of multidisciplinary treatment planning for sarcomas with Dr. Yvette Ho and Dr. Jessica Jones.
This podcast is supported by
More from Dr. Jessica Jones
About
Jessica Treviño Jones, MD, is an associate professor in the Division of Hematology-Oncology at The University of Texas Health Science Center at San Antonio and a breast medical oncologist at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center. She is also the founder and director of Mays Cancer Center's Cancer Risk Reduction and Education Clinic. After earning her medical degree from The University of Texas Health Science Center San Antonio, Jones completed a residency in internal medicine followed by a hematology-oncology fellowship with a focus on breast cancer. She is a first-generation Hispanic college graduate.
Jones began her career at UTHealth Houston, where she pioneered the McGovern Medical School’s Breast Cancer Prevention Program, emphasizing proactive healthcare strategies. Her commitment to education earned her the prestigious Joe R. and Teresa Lozano Long Presidential Scholar award during medical school and subsequent accolades, such as the Dean’s Special Recognition for Teaching Excellence.
Jones collaborates with research clinicians across Texas, including UT Health Rio Grande Valley. As a breast oncologist and cancer prevention expert, she focuses on risk reduction, adherence and improving the quality of life for her patients, particularly those in underserved communities at higher risk of breast cancer. Her advocacy extends beyond clinical settings for her patients - Jones often lends her expertise to local and national news syndicates as an expert advisor.
Bone cement: Serious adverse events, some with fatal outcome, associated with the use of bone cements for vertebroplasty, kyphoplasty and sacroplasty include myocardial infarction, cardiac arrest, cerebrovascular accident, pulmonary embolism and cardiac embolism. Although it is rare, some adverse events have been known to occur beyond one year post-operatively. Additional risks exist with the use of bone cement. Please see the IFU for a complete list of potential risks.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.